JORDANIA GRULLON: Open Payments
NPI 1679298400 · WILKES BARRE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,117 in 59 payments from 17 companies in 2025. Trend: 2023 $1,179 · 2024 $2,070 · 2025 $1,117
Food & beverage: $1,117
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $186 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $144 |
| Phathom Pharmaceuticals, Inc. | 7 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $98 |
| Celltrion USA Inc. | 4 | $90 |
| QOL Medical, LLC | 4 | $87 |
| ABBVIE INC. | 4 | $71 |
| Lilly USA, LLC | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 3 | $47 |
| Gilead Sciences, Inc. | 2 | $45 |
Products named: TREMFYA, XIFAXAN, VOQUEZNA, VEGZELMA, Sucraid, DUPIXENT, ENTYVIO, OMVOH.
Industry payments across PA — which companies pay providers there.
